Panagiotis Nomikos, Rudolf Fahlbusch, Michael Buchfelder
Despite recent and ongoing advances in the pharmacological and radiotherapeutic management of pituitary tumors, surgery remains the therapy of choice for the vast majority of these lesions. Both transsphenoidal and transcranial microsurgery of pituitary adenomas and of other sella lesions are well established, safe and highly efficient therapeutic procedures…
Monica Livia Gheorghiu, Simona Găloiu, Mădălina Vintilă, Mariana Purice, Dan Hortopan, Anda Dumitraşcu, Mihail Coculescu, Cătălina Poiană
BACKGROUND: Somatostatin analogs (SSA) are now considered standard therapy for acromegaly, as primary or adjunctive treatment after pituitary surgery. OBJECTIVE: To evaluate the efficacy of SSA and the effect of dose escalation in non-operated patients with acromegaly as compared to patients treated after pituitary surgery in a Romanian tertiary care center …